Please provide your email address to receive an email when new articles are posted on . Week-22 remission rates were 81% among patients using infliximab and 56% in those on cyclophosphamide. Mild to ...
The MarketWatch News Department was not involved in the creation of this content. -- Study results support advancing SGX945 in this difficult-to-treat orphan disease -- Results suggest potential ...
Please provide your email address to receive an email when new articles are posted on . Adalimumab plus corticosteroids significantly outperformed cyclosporine plus corticosteroids to delay Behçet’s ...
PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
Stocktwits on MSN
SNGX stock slumps to record low after lymphoma trial fails – all eyes now on Behçet’s disease treatment
The trial was evaluating HyBryte in a rare form of cancer with limited treatment options. ・The company also plans to assess ...
Behçet's syndrome is a form of autoimmune vasculitis marked by widespread and sometimes life-threatening cardiovascular complications, as well as skin, nervous system, and gastrointestinal lesions.
A Bengaluru teenager has successfully undergone a rare surgery to repair a life-threatening aortic aneurysm caused by ...
Behçet's disease is a complex, multisystem inflammatory disorder characterised by recurrent mucocutaneous lesions, ocular involvement, and vascular, neurological, and gastrointestinal manifestations.
The EULAR recommendations for the management of Behçet's syndrome were first published in 2008, and updated in 2018. Since that time, new evidence has become available, including trials of biologic ...
PRINCETON, N.J., March 26, 2026 /PRNewswire/ --Soligenix, Inc. (SNGX) (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing ...
Methods We conducted a phase 2, multicenter, placebo-controlled study in which 111 patients with Behçet’s syndrome who had two or more oral ulcers were randomly assigned to receive 30 mg of apremilast ...
Behçet's disease (BD) is a multisystem inflammatory disorder currently classified as a vasculitis. Its etiopathogenesis is unclear, but environmental, genetic and autoimmune factors have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results